CIBC Upgrades Syneron Medical

Analyst John Calcagnini believes the aesthetic medical treatment company's Vela Smooth cellulite product has market potential of $100 million per year

CIBC World upgraded Syneron Medical (ELOS ) to sector outperform from sector perform.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.